PRISM BioLab Co Documenten
Documenten
0
Ticker
206A.T
ISIN
JP3833190006
PRISM BioLab Co SEC Filings
Type | Bericht | Datum |
|---|---|---|
| Geen documenten beschikbaar | ||
PRISM BioLab Co Documenten 2026
Deze pagina bevat alle officiële documenten en SEC-filings voor PRISM BioLab Co aandelen (206A.T, ISIN: JP3833190006). Dit omvat jaarverslagen (Formulier 10-K), kwartaalrapporten (Formulier 10-Q) en insidertransacties (Formulier 4). Momenteel zijn 0 documenten beschikbaar. Gegevens worden regelmatig bijgewerkt om beleggers een volledig overzicht van PRISM BioLab Co's regelgevingsfilings te bieden.
PRISM BioLab Co Aandelenanalyse
PRISM BioLab Co PRISM BioLab Co Ltd, headquartered in Fujisawa-shi, Kanagawa-ken, Japan, operates in the Pharmaceuticals sector within the Health Care industry. The company employs 17 full-time staff and is listed on 2 July 2024. PRISM BioLab focuses on drug discovery, utilizing its proprietary PepMetics technology to develop new pharmaceuticals. It operates through two business models: in-house development of drug discovery programs and joint development collaborations with pharmaceutical companies to target specific drug discovery opportunities.